Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

GRAAPH study - B-ALL, cycle 2 and 4, arm A, Ph/BCR-ABL+, 18-44 years

Protocol-ID: 998 V1.0 (Mini), STUDY-GRAAPH- B-ALL, C2A, Z4A, Ph/BCR-ABL+, 18-44

Indication(s)

  • Acute Lymphoblastic Leukaemia (Ph/BCR-ABL+, B-ALL); ICD-10 C91.0-

Links

  • A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults (GRAAPH2014) [URL]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 22.11.2017